AI assistant
Natco Pharma Ltd. — Regulatory Filings 2021
Feb 3, 2021
62741_rns_2021-02-03_cf43d80b-9ff0-4443-bc05-016f825fc401.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
==> picture [433 x 45] intentionally omitted <==
February 3, 2021
Corporate Relationship Department Manager – Listing M/s. BSE Limited M/s. National Stock Exchange of India Ltd Dalal Street, Fort “Exchange Plaza”, Bandra – Kurla Complex Mumbai 400 001 . Bandra (E) Mumbai 400 051 . Scrip Code: 524816 Scrip Code: NATCOPHARM
Dear Sir/Madam,
Sub: Notice of Board Meeting under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
This is to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Thursday, the 11[th] day of February 2021 to consider among other things, the following items of business and related matters:
| Sl.No. | Item of Business |
|---|---|
| 1 | To consider the Unaudited Financial Results for the quarter and nine monthsended 31stDecember,2020 |
| 2 | To consider third interim dividend,if any,for the financialyear 2020-21 |
Please further note that pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 , as amended from time to time TRADING WINDOW for dealing in the securities of the Company by the Employee(s) and their immediate relatives will be closed from 4[th] February, 2021 to 13[th] February, 2021 (both days inclusive). Trading window will be re-opened on 15[th] February 2021 .
Thanking you,
Yours faithfully, For NATCO PHARMA LIMITED
ADINARAYANA MADINEEDI Digitally signed by ADINARAYANA MADINEEDI DN: c=IN, o=Personal, 2.5.4.20=98307de121abc9bab67f3e00bc3fdead0597f7b7c44a25eaab89442f8748d254, postalCode=500017, st=TELANGANA, serialNumber=3da487f04b8912870dea3f277d9e87fc06da96e80b36d2beb1428dfe3f665de7, cn=ADINARAYANA MADINEEDI Date: 2021.02.03 15:06:52 +05'30' M. Adinarayana Company Secretary & Vice President(Legal & Corp. Affairs)